BENEO Celebrates Anniversary of galenIQ at CPhI

Article

The company celebrates the 10th anniversary of its filler-binder excipient at CPhI Worldwide.

BENEO celebrated the 10th anniversary of the company’s water-soluble filler-binder excipient, galenIQ, at CPhI Worldwide in October 2015.  The filler-binder is derived from beet sugar, has a mildly sweet, sugar-like taste, and is useful in plant extract and pediatric formulations.

During the past decade, BENEO’s continuous investment in developing galenIQ’s performance has increased the number of available grades to meet the specific requirements of different pharmaceutical applications, following the original launch of agglomerated product grades 720 and 721 for direct compression, with eight different grades, all of which have a shelf-life of 36 and 60 months, respectively.

The galenIQ range offers specific free-flowing and highly compressible grades for direct compression. Additional grades are available for wet granulation and processing technologies such as hot-melt extrusion, roller compaction, fluid bed agglomeration and film and sugar coating, and as a sugar-free starter core for multiple unit systems.  The grades’ specific morphology promotes high content uniformity, ideal for both very high- and low-dose applications.

Michael Black, head of sales pharma, commented: “It’s a great time to look back at ten years of success and positive development. galenIQ is globally recognized and appreciated for its unique characteristics and, in particular, for contributing to the palatability of many pharmaceutical products which is especially important in pediatrics and veterinary medicines. There are promising opportunities ahead, though, and we are constantly investigating the sensorial advantages that can be achieved with this highly versatile excipient.”

Source: BENEO

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content